Over 5000 high-risk cancer gene variants identified
25 July, 2024UK researchers assessed the health impact of all possible genetic changes in the so-called 'tumour protection' gene, finding that over 5000 of these possible changes are pathogenic.
Small molecule could help treat Angelman syndrome
24 July, 2024Angelman syndrome is a rare genetic disorder characterised by poor muscle control, limited speech, epilepsy and intellectual disabilities.
MGI Tech DNBSEQ-G400RS FluoXpert multi-omics instrument
18 July, 2024MGI Tech's DNBSEQ-G400RS FluoXpert is a multifunctional sequencer that is compatible with in vivo spatial protein detection.
3D genome reconstructed from freeze-dried woolly mammoth
15 July, 2024An international research team has assembled a 3D reconstruction of the genome and chromosomal structures of a 52,000-year-old woolly mammoth.
Identifying the genetic 'switches' of bone growth
25 June, 2024Researchers have located 2700 genome sequences that precisely regulate the genes responsible for bone growth, shedding light on one of the major factors influencing the size of individuals in adulthood.
Bio-Rad Laboratories ddSEQ Single-Cell 3′ RNA-Seq Kit
20 June, 2024The kit delivers high-quality single-cell 3′ RNA-Seq libraries in a fast, efficient workflow, allowing researchers to easily conduct single-cell gene expression and regulation analyses.
Twist Multiplexed Gene Fragments
17 June, 2024Twist Multiplexed Gene Fragments offer a novel pooled format for up to hundreds of thousands of gene fragments, between 301 and 500 base pairs in length.
Gene therapy for frontotemporal dementia
13 June, 2024A new therapeutic approach for treating frontotemporal dementia — an incurable brain disease — uses modified viruses to replace a missing protein in the brain.
Revvity Horizon Discovery Pin-point Base Editing Platform
24 May, 2024The Horizon Discovery Pin-point Base Editing platform from Revvity, with its novel three-part design and strong safety profile, is designed to enhance base editing's capabilities by enabling simultaneous modification of several genes at once.
ACROBiosystems target antigens for CAR-T therapy development
24 May, 2024ACROBiosystems' growing list of proteins includes many fluorescent-labelled target antigens and pre-biotinylated proteins that are suitable for evaluating CAR expression.
Cell-mapping project to uncover genetic fingerprints of disease
22 May, 2024The $27m project will see researchers map 50 million human cells from 10,000 people to identify unique genomic fingerprints of autoimmune diseases, heart diseases and cancer.
Fast growth during puberty linked to long-term health conditions
20 May, 2024Being taller at early puberty and experiencing quicker pubertal growth were associated with an increased risk of atrial fibrillation — an irregular and abnormally fast heart rate.
Gene editing could make quolls resistant to cane toad toxin
14 May, 2024Scientists from Colossal Biosciences and The University of Melbourne have introduced genetic resistance against the cane toad toxin into marsupial cells.
Genetic cause found for rare neurological disease
09 May, 2024The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare movement disorder with no known cure and, until recently, no known cause.
OGT SureSeq Myeloid Fusion Panel
07 May, 2024The RNA-based SureSeq Myeloid Fusion Panel is a next-generation sequencing (NGS) tool for identifying key fusion genes implicated in acute myeloid leukaemia (AML).
